Nitroprusside for Prevention of no-Reflow in Primary Angioplasty
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
In patients admitted with acute myocardial infarction, there is a total occlusion of a
coronary artery. Even after emergency catheterization and angioplasty, in some patients, the
resumed blood flow is suboptimal and impacts on heart function. The study is aimed at
examining whether nitroprusside, an anti-hypertension medication, given directly into the
coronary artery, can improve the blood flow after the removal of the obstruction that caused
the infarction.